Uric acid is the main metabolite of birds and reptiles. It is slightly soluble in water and easily forms crystals. The product in normal human urine is mainly urea, which contains a small amount of uric acid. Uric acid is the final product of purine metabolism. It is trioxypurine and its alcohol form is weakly acidic. People with high uric acid will have a serious problem in health.

The global market for Uric Acid Drug was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Uric Acid Drug, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Uric Acid Drug by region & country, by Type, and by Application.

The Uric Acid Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Uric Acid Drug.

Market Segmentation

Scope of Uric Acid Drug - Market Report

Report Metric	Details
Report Name	Uric Acid Drug - Market
CAGR	5%
Segment by Type:	Allopurinol Febuxostat Probenecid
Segment by Application	Online Pharmacies Retail Pharmacies Hospital Pharmacies
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AstraZeneca plc, Boehringer Ingelheim GmbH, Teijin Pharma Ltd, Regeneron Pharmaceuticals, GlaxoSmithKline plc, Merck & Co. Inc, Novartis AG, Savient Pharmaceuticals, Ironwood Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Uric Acid Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Uric Acid Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Uric Acid Drug in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Uric Acid Drug - Market report?

Ans: The main players in the Uric Acid Drug - Market are AstraZeneca plc, Boehringer Ingelheim GmbH, Teijin Pharma Ltd, Regeneron Pharmaceuticals, GlaxoSmithKline plc, Merck & Co. Inc, Novartis AG, Savient Pharmaceuticals, Ironwood Pharmaceuticals

What are the Application segmentation covered in the Uric Acid Drug - Market report?

Ans: The Applications covered in the Uric Acid Drug - Market report are Online Pharmacies, Retail Pharmacies, Hospital Pharmacies

What are the Type segmentation covered in the Uric Acid Drug - Market report?

Ans: The Types covered in the Uric Acid Drug - Market report are Allopurinol, Febuxostat, Probenecid

1 Market Overview

1.1 Uric Acid Drug Product Introduction

1.2 Global Uric Acid Drug Market Size Forecast

1.2.1 Global Uric Acid Drug Sales Value (2019-2030)

1.2.2 Global Uric Acid Drug Sales Volume (2019-2030)

1.2.3 Global Uric Acid Drug Sales Price (2019-2030)

1.3 Uric Acid Drug Market Trends & Drivers

1.3.1 Uric Acid Drug Industry Trends

1.3.2 Uric Acid Drug Market Drivers & Opportunity

1.3.3 Uric Acid Drug Market Challenges

1.3.4 Uric Acid Drug Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Uric Acid Drug Players Revenue Ranking (2023)

2.2 Global Uric Acid Drug Revenue by Company (2019-2024)

2.3 Global Uric Acid Drug Players Sales Volume Ranking (2023)

2.4 Global Uric Acid Drug Sales Volume by Company Players (2019-2024)

2.5 Global Uric Acid Drug Average Price by Company (2019-2024)

2.6 Key Manufacturers Uric Acid Drug Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Uric Acid Drug Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Uric Acid Drug

2.9 Uric Acid Drug Market Competitive Analysis

2.9.1 Uric Acid Drug Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Uric Acid Drug Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Uric Acid Drug as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Allopurinol

3.1.2 Febuxostat

3.1.3 Probenecid

3.2 Global Uric Acid Drug Sales Value by Type

3.2.1 Global Uric Acid Drug Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Uric Acid Drug Sales Value, by Type (2019-2030)

3.2.3 Global Uric Acid Drug Sales Value, by Type (%) (2019-2030)

3.3 Global Uric Acid Drug Sales Volume by Type

3.3.1 Global Uric Acid Drug Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Uric Acid Drug Sales Volume, by Type (2019-2030)

3.3.3 Global Uric Acid Drug Sales Volume, by Type (%) (2019-2030)

3.4 Global Uric Acid Drug Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Online Pharmacies

4.1.2 Retail Pharmacies

4.1.3 Hospital Pharmacies

4.2 Global Uric Acid Drug Sales Value by Application

4.2.1 Global Uric Acid Drug Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Uric Acid Drug Sales Value, by Application (2019-2030)

4.2.3 Global Uric Acid Drug Sales Value, by Application (%) (2019-2030)

4.3 Global Uric Acid Drug Sales Volume by Application

4.3.1 Global Uric Acid Drug Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Uric Acid Drug Sales Volume, by Application (2019-2030)

4.3.3 Global Uric Acid Drug Sales Volume, by Application (%) (2019-2030)

4.4 Global Uric Acid Drug Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Uric Acid Drug Sales Value by Region

5.1.1 Global Uric Acid Drug Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Uric Acid Drug Sales Value by Region (2019-2024)

5.1.3 Global Uric Acid Drug Sales Value by Region (2025-2030)

5.1.4 Global Uric Acid Drug Sales Value by Region (%), (2019-2030)

5.2 Global Uric Acid Drug Sales Volume by Region

5.2.1 Global Uric Acid Drug Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Uric Acid Drug Sales Volume by Region (2019-2024)

5.2.3 Global Uric Acid Drug Sales Volume by Region (2025-2030)

5.2.4 Global Uric Acid Drug Sales Volume by Region (%), (2019-2030)

5.3 Global Uric Acid Drug Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Uric Acid Drug Sales Value, 2019-2030

5.4.2 North America Uric Acid Drug Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Uric Acid Drug Sales Value, 2019-2030

5.5.2 Europe Uric Acid Drug Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Uric Acid Drug Sales Value, 2019-2030

5.6.2 Asia Pacific Uric Acid Drug Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Uric Acid Drug Sales Value, 2019-2030

5.7.2 South America Uric Acid Drug Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Uric Acid Drug Sales Value, 2019-2030

5.8.2 Middle East & Africa Uric Acid Drug Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Uric Acid Drug Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Uric Acid Drug Sales Value

6.2.1 Key Countries/Regions Uric Acid Drug Sales Value, 2019-2030

6.2.2 Key Countries/Regions Uric Acid Drug Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Uric Acid Drug Sales Value, 2019-2030

6.3.2 United States Uric Acid Drug Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Uric Acid Drug Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Uric Acid Drug Sales Value, 2019-2030

6.4.2 Europe Uric Acid Drug Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Uric Acid Drug Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Uric Acid Drug Sales Value, 2019-2030

6.5.2 China Uric Acid Drug Sales Value by Type (%), 2023 VS 2030

6.5.3 China Uric Acid Drug Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Uric Acid Drug Sales Value, 2019-2030

6.6.2 Japan Uric Acid Drug Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Uric Acid Drug Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Uric Acid Drug Sales Value, 2019-2030

6.7.2 South Korea Uric Acid Drug Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Uric Acid Drug Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Uric Acid Drug Sales Value, 2019-2030

6.8.2 Southeast Asia Uric Acid Drug Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Uric Acid Drug Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Uric Acid Drug Sales Value, 2019-2030

6.9.2 India Uric Acid Drug Sales Value by Type (%), 2023 VS 2030

6.9.3 India Uric Acid Drug Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 AstraZeneca plc

7.1.1 AstraZeneca plc Company Information

7.1.2 AstraZeneca plc Introduction and Business Overview

7.1.3 AstraZeneca plc Uric Acid Drug Sales, Revenue and Gross Margin (2019-2024)

7.1.4 AstraZeneca plc Uric Acid Drug Product Offerings

7.1.5 AstraZeneca plc Recent Development

7.2 Boehringer Ingelheim GmbH

7.2.1 Boehringer Ingelheim GmbH Company Information

7.2.2 Boehringer Ingelheim GmbH Introduction and Business Overview

7.2.3 Boehringer Ingelheim GmbH Uric Acid Drug Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Boehringer Ingelheim GmbH Uric Acid Drug Product Offerings

7.2.5 Boehringer Ingelheim GmbH Recent Development

7.3 Teijin Pharma Ltd

7.3.1 Teijin Pharma Ltd Company Information

7.3.2 Teijin Pharma Ltd Introduction and Business Overview

7.3.3 Teijin Pharma Ltd Uric Acid Drug Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Teijin Pharma Ltd Uric Acid Drug Product Offerings

7.3.5 Teijin Pharma Ltd Recent Development

7.4 Regeneron Pharmaceuticals

7.4.1 Regeneron Pharmaceuticals Company Information

7.4.2 Regeneron Pharmaceuticals Introduction and Business Overview

7.4.3 Regeneron Pharmaceuticals Uric Acid Drug Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Regeneron Pharmaceuticals Uric Acid Drug Product Offerings

7.4.5 Regeneron Pharmaceuticals Recent Development

7.5 GlaxoSmithKline plc

7.5.1 GlaxoSmithKline plc Company Information

7.5.2 GlaxoSmithKline plc Introduction and Business Overview

7.5.3 GlaxoSmithKline plc Uric Acid Drug Sales, Revenue and Gross Margin (2019-2024)

7.5.4 GlaxoSmithKline plc Uric Acid Drug Product Offerings

7.5.5 GlaxoSmithKline plc Recent Development

7.6 Merck & Co. Inc

7.6.1 Merck & Co. Inc Company Information

7.6.2 Merck & Co. Inc Introduction and Business Overview

7.6.3 Merck & Co. Inc Uric Acid Drug Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Merck & Co. Inc Uric Acid Drug Product Offerings

7.6.5 Merck & Co. Inc Recent Development

7.7 Novartis AG

7.7.1 Novartis AG Company Information

7.7.2 Novartis AG Introduction and Business Overview

7.7.3 Novartis AG Uric Acid Drug Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Novartis AG Uric Acid Drug Product Offerings

7.7.5 Novartis AG Recent Development

7.8 Savient Pharmaceuticals

7.8.1 Savient Pharmaceuticals Company Information

7.8.2 Savient Pharmaceuticals Introduction and Business Overview

7.8.3 Savient Pharmaceuticals Uric Acid Drug Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Savient Pharmaceuticals Uric Acid Drug Product Offerings

7.8.5 Savient Pharmaceuticals Recent Development

7.9 Ironwood Pharmaceuticals

7.9.1 Ironwood Pharmaceuticals Company Information

7.9.2 Ironwood Pharmaceuticals Introduction and Business Overview

7.9.3 Ironwood Pharmaceuticals Uric Acid Drug Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Ironwood Pharmaceuticals Uric Acid Drug Product Offerings

7.9.5 Ironwood Pharmaceuticals Recent Development

8 Industry Chain Analysis

8.1 Uric Acid Drug Industrial Chain

8.2 Uric Acid Drug Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Uric Acid Drug Sales Model

8.5.2 Sales Channel

8.5.3 Uric Acid Drug Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Astrazeneca plc

Boehringer Ingelheim GmbH

Teijin Pharma Ltd

Regeneron Pharmaceuticals

GlaxoSmithKline PLC

Merck& Co. Inc

Novartis

Savient Pharmaceuticals

Ironwood Pharmaceuticals

List of Tables

Table 1. Uric Acid Drug Market Trends

Table 2. Uric Acid Drug Market Drivers & Opportunity

Table 3. Uric Acid Drug Market Challenges

Table 4. Uric Acid Drug Market Restraints

Table 5. Global Uric Acid Drug Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Uric Acid Drug Revenue Market Share by Company (2019-2024)

Table 7. Global Uric Acid Drug Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Uric Acid Drug Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Uric Acid Drug Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Uric Acid Drug Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Uric Acid Drug Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Uric Acid Drug

Table 13. Global Uric Acid Drug Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Uric Acid Drug as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Uric Acid Drug Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Uric Acid Drug Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Uric Acid Drug Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Uric Acid Drug Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Uric Acid Drug Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Uric Acid Drug Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Uric Acid Drug Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Uric Acid Drug Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Uric Acid Drug Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Uric Acid Drug Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Uric Acid Drug Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Uric Acid Drug Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Uric Acid Drug Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Uric Acid Drug Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Uric Acid Drug Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Uric Acid Drug Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Uric Acid Drug Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Uric Acid Drug Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Uric Acid Drug Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Uric Acid Drug Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Uric Acid Drug Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Uric Acid Drug Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Uric Acid Drug Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Uric Acid Drug Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Uric Acid Drug Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Uric Acid Drug Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Uric Acid Drug Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Uric Acid Drug Sales Value by Region (2019-2024) & (%)

Table 44. Global Uric Acid Drug Sales Value by Region (2025-2030) & (%)

Table 45. Global Uric Acid Drug Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Uric Acid Drug Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Uric Acid Drug Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Uric Acid Drug Sales Volume by Region (2019-2024) & (%)

Table 49. Global Uric Acid Drug Sales Volume by Region (2025-2030) & (%)

Table 50. Global Uric Acid Drug Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Uric Acid Drug Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Uric Acid Drug Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Uric Acid Drug Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Uric Acid Drug Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Uric Acid Drug Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Uric Acid Drug Sales Volume, (2025-2030) & (K Units)

Table 57. AstraZeneca plc Company Information

Table 58. AstraZeneca plc Introduction and Business Overview

Table 59. AstraZeneca plc Uric Acid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. AstraZeneca plc Uric Acid Drug Product Offerings

Table 61. AstraZeneca plc Recent Development

Table 62. Boehringer Ingelheim GmbH Company Information

Table 63. Boehringer Ingelheim GmbH Introduction and Business Overview

Table 64. Boehringer Ingelheim GmbH Uric Acid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Boehringer Ingelheim GmbH Uric Acid Drug Product Offerings

Table 66. Boehringer Ingelheim GmbH Recent Development

Table 67. Teijin Pharma Ltd Company Information

Table 68. Teijin Pharma Ltd Introduction and Business Overview

Table 69. Teijin Pharma Ltd Uric Acid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. Teijin Pharma Ltd Uric Acid Drug Product Offerings

Table 71. Teijin Pharma Ltd Recent Development

Table 72. Regeneron Pharmaceuticals Company Information

Table 73. Regeneron Pharmaceuticals Introduction and Business Overview

Table 74. Regeneron Pharmaceuticals Uric Acid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. Regeneron Pharmaceuticals Uric Acid Drug Product Offerings

Table 76. Regeneron Pharmaceuticals Recent Development

Table 77. GlaxoSmithKline plc Company Information

Table 78. GlaxoSmithKline plc Introduction and Business Overview

Table 79. GlaxoSmithKline plc Uric Acid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. GlaxoSmithKline plc Uric Acid Drug Product Offerings

Table 81. GlaxoSmithKline plc Recent Development

Table 82. Merck & Co. Inc Company Information

Table 83. Merck & Co. Inc Introduction and Business Overview

Table 84. Merck & Co. Inc Uric Acid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. Merck & Co. Inc Uric Acid Drug Product Offerings

Table 86. Merck & Co. Inc Recent Development

Table 87. Novartis AG Company Information

Table 88. Novartis AG Introduction and Business Overview

Table 89. Novartis AG Uric Acid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. Novartis AG Uric Acid Drug Product Offerings

Table 91. Novartis AG Recent Development

Table 92. Savient Pharmaceuticals Company Information

Table 93. Savient Pharmaceuticals Introduction and Business Overview

Table 94. Savient Pharmaceuticals Uric Acid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 95. Savient Pharmaceuticals Uric Acid Drug Product Offerings

Table 96. Savient Pharmaceuticals Recent Development

Table 97. Ironwood Pharmaceuticals Company Information

Table 98. Ironwood Pharmaceuticals Introduction and Business Overview

Table 99. Ironwood Pharmaceuticals Uric Acid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 100. Ironwood Pharmaceuticals Uric Acid Drug Product Offerings

Table 101. Ironwood Pharmaceuticals Recent Development

Table 102. Key Raw Materials Lists

Table 103. Raw Materials Key Suppliers Lists

Table 104. Uric Acid Drug Downstream Customers

Table 105. Uric Acid Drug Distributors List

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

List of Figures

Figure 1. Uric Acid Drug Product Picture

Figure 2. Global Uric Acid Drug Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Uric Acid Drug Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Uric Acid Drug Sales Volume (2019-2030) & (K Units)

Figure 5. Global Uric Acid Drug Sales Price (2019-2030) & (US$/Unit)

Figure 6. Uric Acid Drug Report Years Considered

Figure 7. Global Uric Acid Drug Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Uric Acid Drug Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Uric Acid Drug Revenue in 2023

Figure 10. Uric Acid Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Allopurinol Picture

Figure 12. Febuxostat Picture

Figure 13. Probenecid Picture

Figure 14. Global Uric Acid Drug Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 15. Global Uric Acid Drug Sales Value Market Share by Type, 2023 & 2030

Figure 16. Global Uric Acid Drug Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 17. Global Uric Acid Drug Sales Volume Market Share by Type, 2023 & 2030

Figure 18. Global Uric Acid Drug Price by Type (2019-2030) & (US$/Unit)

Figure 19. Product Picture of Online Pharmacies

Figure 20. Product Picture of Retail Pharmacies

Figure 21. Product Picture of Hospital Pharmacies

Figure 22. Global Uric Acid Drug Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 23. Global Uric Acid Drug Sales Value Market Share by Application, 2023 & 2030

Figure 24. Global Uric Acid Drug Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 25. Global Uric Acid Drug Sales Volume Market Share by Application, 2023 & 2030

Figure 26. Global Uric Acid Drug Price by Application (2019-2030) & (US$/Unit)

Figure 27. North America Uric Acid Drug Sales Value (2019-2030) & (US$ Million)

Figure 28. North America Uric Acid Drug Sales Value by Country (%), 2023 VS 2030

Figure 29. Europe Uric Acid Drug Sales Value (2019-2030) & (US$ Million)

Figure 30. Europe Uric Acid Drug Sales Value by Country (%), 2023 VS 2030

Figure 31. Asia Pacific Uric Acid Drug Sales Value (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Uric Acid Drug Sales Value by Country (%), 2023 VS 2030

Figure 33. South America Uric Acid Drug Sales Value (2019-2030) & (US$ Million)

Figure 34. South America Uric Acid Drug Sales Value by Country (%), 2023 VS 2030

Figure 35. Middle East & Africa Uric Acid Drug Sales Value (2019-2030) & (US$ Million)

Figure 36. Middle East & Africa Uric Acid Drug Sales Value by Country (%), 2023 VS 2030

Figure 37. Key Countries/Regions Uric Acid Drug Sales Value (%), (2019-2030)

Figure 38. Key Countries/Regions Uric Acid Drug Sales Volume (%), (2019-2030)

Figure 39. United States Uric Acid Drug Sales Value, (2019-2030) & (US$ Million)

Figure 40. United States Uric Acid Drug Sales Value by Type (%), 2023 VS 2030

Figure 41. United States Uric Acid Drug Sales Value by Application (%), 2023 VS 2030

Figure 42. Europe Uric Acid Drug Sales Value, (2019-2030) & (US$ Million)

Figure 43. Europe Uric Acid Drug Sales Value by Type (%), 2023 VS 2030

Figure 44. Europe Uric Acid Drug Sales Value by Application (%), 2023 VS 2030

Figure 45. China Uric Acid Drug Sales Value, (2019-2030) & (US$ Million)

Figure 46. China Uric Acid Drug Sales Value by Type (%), 2023 VS 2030

Figure 47. China Uric Acid Drug Sales Value by Application (%), 2023 VS 2030

Figure 48. Japan Uric Acid Drug Sales Value, (2019-2030) & (US$ Million)

Figure 49. Japan Uric Acid Drug Sales Value by Type (%), 2023 VS 2030

Figure 50. Japan Uric Acid Drug Sales Value by Application (%), 2023 VS 2030

Figure 51. South Korea Uric Acid Drug Sales Value, (2019-2030) & (US$ Million)

Figure 52. South Korea Uric Acid Drug Sales Value by Type (%), 2023 VS 2030

Figure 53. South Korea Uric Acid Drug Sales Value by Application (%), 2023 VS 2030

Figure 54. Southeast Asia Uric Acid Drug Sales Value, (2019-2030) & (US$ Million)

Figure 55. Southeast Asia Uric Acid Drug Sales Value by Type (%), 2023 VS 2030

Figure 56. Southeast Asia Uric Acid Drug Sales Value by Application (%), 2023 VS 2030

Figure 57. India Uric Acid Drug Sales Value, (2019-2030) & (US$ Million)

Figure 58. India Uric Acid Drug Sales Value by Type (%), 2023 VS 2030

Figure 59. India Uric Acid Drug Sales Value by Application (%), 2023 VS 2030

Figure 60. Uric Acid Drug Industrial Chain

Figure 61. Uric Acid Drug Manufacturing Cost Structure

Figure 62. Channels of Distribution (Direct Sales, and Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions